Thursday, 19 November 2020

Reuters Health Report: Russia resumes COVID-19 vaccine trial after pause: medical staff

Reuters.com Newsletter

Russia resumes COVID-19 vaccine trial after pause: medical staff

Russia has resumed the vaccination of new volunteers in its trial for its flagship COVID-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population.

AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas

AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.

German health official expects number of COVID-19 infections to fall

The number of new COVID-19 infections in Germany remains far too high but there are signs that the country's "lockdown lite" is working and could reduce numbers soon, health officials said on Thursday.

COVID-19 cases in England rise 11%, proportion of positives stable: tracing service

Cases of COVID-19 rose 11% in England in the latest week, with the proportion of people testing positive staying steady, the country's test and trace programme said on Thursday, adding that contacts reached were still near a record low percentage.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

EU warns Hungary against use of Russia's COVID-19 vaccine

Hungary's plans to import and possibly use Russia's touted Sputnik V COVID-19 vaccine raise safety concerns and could damage trust in potential shots, the European Commission said, opening a new front in the EU's fraught relations with Budapest.

Spain lowers price cap on COVID-19 masks to 62 cents

Spain's health ministry on Thursday lowered the price cap on health masks, mandatory across the country to curb COVID-19 contagion, to 0.62 euros ($0.73) per mask.

Southern Europe rues exodus of doctors, nurses as coronavirus surges

Thirty-year-old Pep Iglesies emigrated to Canada from Spain in August for a new job that is much like his old one – taking care of coronavirus patients and working as a cardiologist.

Oxford COVID-19 trial will look at interim Phase III data after 53 infections: investigator

Oxford University will start an initial analysis of data from its late-stage trial of the experimental COVID-19 vaccine it is developing with AstraZeneca after 53 infections among its volunteers, the study's chief investigator said on Thursday.

Denmark says mutated coronavirus from mink farms most likely extinct

A new, mutated strain of the novel coronavirus stemming from mink farms in Denmark is "most likely" extinct, the health ministry said on Thursday, amid fears the new strain could compromise COVID-19 vaccines.

Lockdowns in Europe avoidable, vaccines 'not a silver bullet': WHO Europe

Fresh lockdowns in Europe are avoidable, including through near-universal mask-wearing, the head of the World Health Organization (WHO) Europe office said on Thursday.

Related Videos

Expert says Covid risk in sport may be minimal

A 'dangerous situation': COVID-19 deaths surge

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS